デフォルト表紙
市場調査レポート
商品コード
1439714

インターベンショナルラジオロジーデバイス - 世界市場の考察、競合情勢、市場予測(2030年)

Interventional Radiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
インターベンショナルラジオロジーデバイス - 世界市場の考察、競合情勢、市場予測(2030年)
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のインターベンショナルラジオロジーデバイスの市場規模は、2024年~2030年の予測期間にCAGRで5.23%の成長が見込まれます。インターベンショナルラジオロジーデバイスに対する需要の増加は主に、慢性疾患やがんの有病率の増加による患者の増加と、世界の高齢患者の増加によるものです。インターベンショナルラジオロジーデバイスは、低侵襲技術で動作するため、重度の外科手術が少なく、入院期間の短縮につながります。そのため、世界中での医療費削減への需要の向上による、このデバイスの市場拡大が見込まれています。さらに、低侵襲技術に対する認識と需要の向上、イルミネーションレンダリング技術、リアルタイム画像などのデバイスの技術の進歩が世界的に市場を強化し、2024年~2030年の予測期間にインターベンショナルラジオロジーデバイス市場の成長に寄与すると見込まれます。

インターベンショナルラジオロジーデバイスの市場力学

インターベンショナルラジオロジーデバイス市場は、さまざまな理由から製品需要が伸びています。

世界中での患者の増加が、市場におけるインターベンショナルラジオロジーデバイスの需要を増大させています。例えば、世界中での遺伝、加齢、肥満、不健康な生活習慣などのさまざまな要因による心不全や脳卒中などの心血管障害の有病率の増加や、慢性疾患を患いやすい高齢患者の増加が市場を強化すると予測されています。世界保健機関(WHO)(2022)によると、2019年、心血管疾患(CVD)は世界最大の死因の1つでした。2019年にCVDが原因で死亡した人は約1,790万人と推定され、全世界の死亡者数の32%を占めています。また、1,790万人の死因のうち、約85%が心臓発作と脳卒中によるものと推定されています。さらに、同じ資料によると、CVDによる死亡の4分の3超は低中所得国で起きていると結論づけられました。WHOは、たばこの使用、不健康な食事や肥満、運動不足、アルコールの有害な使用などの行動の危険因子に対処することで、心血管疾患の大部分を予防できると結論づけました。さらに、心不全の有病率も上昇しています。Global Health Data Exchange(2019)によると、世界全体で6,437万人が心不全を患っていると推定されました。この場合、有病率の増加は、心血管障害の診断と治療に用いる塞栓デバイス、MRIデバイスなどの多くのインターベンショナルラジオロジーデバイスの需要を増加させます。このように、世界中での慢性疾患の有病率の増加は、患者数を増加させ、それによってインターベンショナルラジオロジーデバイスの需要を増加させるため、2022年~2028年の調査期間に市場全体の成長を促進すると予測されます。

さらに、WHO(2022)によると、2030年までに世界の6人に1人が60歳以上の高齢者となります。60歳以上の人口に占める割合は、2020年の10億人から世界全体で14億人に増加します。2050年までに、世界の60歳以上人口は2倍になります。80歳以上の人口は、2020年~2050年に3倍の4億2,600万人に達すると予測されています。このように、老年人口が増加することは、加齢が慢性疾患の主な危険因子の1つであることから、慢性疾患の有病率に影響を与えます。慢性疾患の有病率の増加は、結果として全体的な患者数を増加させ、市場におけるインターベンショナルラジオロジーデバイスの需要の増加につながります。したがって、上記の要因が予測期間におけるインターベンショナルラジオロジーデバイス市場を強化します。

さらに、インターベンショナルラジオロジーデバイスの大半は低侵襲デバイスであり、これらのデバイスは体に大きな切り込みを入れないため、入院期間が短縮され、患者の早期回復につながります。そのため、入院期間の短縮やコスト削減へのニーズの急増から、こうしたデバイスの需要が高まります。したがって、上記の要因が2023年~2028年のインターベンショナルラジオロジーデバイス市場全体の成長を促進すると予測されます。

当レポートでは、世界のインターベンショナルラジオロジーデバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 インターベンショナルラジオロジーデバイス市場レポートのイントロダクション

第2章 インターベンショナルラジオロジーデバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 インターベンショナルラジオロジーデバイス市場の主な要因の分析

  • インターベンショナルラジオロジーデバイス市場の促進要因
    • 世界の慢性疾患とがんの有病率の増加と高齢患者の増加による患者数の増加
    • 入院期間の短縮による医療支出の削減への需要の高まり
    • 低侵襲治療に対する意識と需要の高まり
    • イルミネーションレンダリング技術やリアルタイム画像などのデバイスの技術の進歩
  • インターベンショナルラジオロジーデバイス市場の抑制要因と課題
    • ラジオロジーデバイスの高いコスト
    • 遠隔地における熟練した専門家の不足
  • インターベンショナルラジオロジーデバイス市場の機会
    • 先進のアルゴリズムやAIなどを搭載したシステムへの需要の増加

第5章 インターベンショナルラジオロジーデバイス市場のポーターのファイブフォース分析

第6章 インターベンショナルラジオロジーデバイス市場に対するCOVID-19の影響分析

第7章 インターベンショナルラジオロジーデバイス市場のレイアウト

  • 製品タイプ別
    • MRIシステム
    • CTスキャナー
    • 超音波画像診断システム
    • 血管造影システム
    • 生検デバイス
    • その他
  • 用途別
    • 心臓
    • 腫瘍
    • 泌尿器科
    • 消化器科
    • 産科
  • エンドユーザー別
    • 病院・診療所
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 インターベンショナルラジオロジーデバイス市場:世界の企業シェア分析 - 主要3~5社

第9章 インターベンショナルラジオロジーデバイス市場の企業と製品のプロファイル

  • General Electric
  • Koninklijke Philips N.V.
  • Carestream Health
  • ESAOTE SPA
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • CANON MEDICAL SYSTEMS CORPORATION
  • Samsung Medison Co., Ltd.
  • Medtronic
  • Agfa-Gevaert Group
  • Teleflex Incorporated
  • Cook
  • Analogic Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Trivitron Healthcare
  • Stryker Corporation
  • Olympus Corporation
  • Toshiba Medical Systems

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Interventional Radiology Devices Market in Global (2021-2030)
  • Table 4: Interventional Radiology Devices Market in Global by Product Type (2021-2030)
  • Table 5: Interventional Radiology Devices Market in Global by Application (2021-2030)
  • Table 6: Interventional Radiology Devices Market in Global by End User (2021-2030)
  • Table 7: Interventional Radiology Devices Market in Global by Geography (2021-2030)
  • Table 8: Interventional Radiology Devices Market in North America (2021-2030)
  • Table 9: Interventional Radiology Devices Market in North America by Country (2021-2030)
  • Table 10: Interventional Radiology Devices Market in the US (2021-2030)
  • Table 11: Interventional Radiology Devices Market in Canada (2021-2030)
  • Table 12: Interventional Radiology Devices Market in Mexico (2021-2030)
  • Table 13: Interventional Radiology Devices Market in Europe (2021-2030)
  • Table 14: Interventional Radiology Devices Market in Europe by Country (2021-2030)
  • Table 15: Interventional Radiology Devices Market in France (2021-2030)
  • Table 16: Interventional Radiology Devices Market in Germany (2021-2030)
  • Table 17: Interventional Radiology Devices Market in the United Kingdom (2021-2030)
  • Table 18: Interventional Radiology Devices Market in Italy (2021-2030)
  • Table 19: Interventional Radiology Devices Market in Spain (2021-2030)
  • Table 20: Interventional Radiology Devices Market in Russia (2021-2030)
  • Table 21: Interventional Radiology Devices Market in Rest of Europe (2021-2030)
  • Table 22: Interventional Radiology Devices Market in APAC (2021-2030)
  • Table 23: Interventional Radiology Devices Market in APAC by Country (2021-2030)
  • Table 24: Interventional Radiology Devices Market in China (2021-2030)
  • Table 25: Interventional Radiology Devices Market in Japan (2021-2030)
  • Table 26: Interventional Radiology Devices Market in India (2021-2030)
  • Table 27: Interventional Radiology Devices Market in Australia (2021-2030)
  • Table 28: Interventional Radiology Devices Market in South Korea (2021-2030)
  • Table 29: Interventional Radiology Devices Market in Rest of APAC (2021-2030)
  • Table 30: Interventional Radiology Devices Market in Rest of World (2021-2030)
  • Table 31: Interventional Radiology Devices Market in RoW by Region (2021-2030)
  • Table 32: Interventional Radiology Devices Market in Middle East (2021-2030)
  • Table 33: Interventional Radiology Devices Market in Africa (2021-2030)
  • Table 34: Interventional Radiology Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Interventional Radiology Devices Market in Global (2021-2030)
  • Figure 4: Interventional Radiology Devices Market in Global by Product Type (2021-2030)
  • Figure 5: Interventional Radiology Devices Market in Global by Application (2021-2030)
  • Figure 6: Interventional Radiology Devices Market in Global by End User (2021-2030)
  • Figure 7: Interventional Radiology Devices Market in Global by Geography (2021-2030)
  • Figure 8: Interventional Radiology Devices Market in North America (2021-2030)
  • Figure 9: Interventional Radiology Devices Market in North America by Country (2021-2030)
  • Figure 10: Interventional Radiology Devices Market in the US (2021-2030)
  • Figure 11: Interventional Radiology Devices Market in Canada (2021-2030)
  • Figure 12: Interventional Radiology Devices Market in Mexico (2021-2030)
  • Figure 13: Interventional Radiology Devices Market in Europe (2021-2030)
  • Figure 14: Interventional Radiology Devices Market in Europe by Country (2021-2030)
  • Figure 15: Interventional Radiology Devices Market in France (2021-2030)
  • Figure 16: Interventional Radiology Devices Market in Germany (2021-2030)
  • Figure 17: Interventional Radiology Devices Market in the United Kingdom (2021-2030)
  • Figure 18: Interventional Radiology Devices Market in Italy (2021-2030)
  • Figure 19: Interventional Radiology Devices Market in Spain (2021-2030)
  • Figure 20: Interventional Radiology Devices Market in Russia (2021-2030)
  • Figure 21: Interventional Radiology Devices Market in Rest of Europe (2021-2030)
  • Figure 22: Interventional Radiology Devices Market in APAC (2021-2030)
  • Figure 23: Interventional Radiology Devices Market in APAC by Country (2021-2030)
  • Figure 24: Interventional Radiology Devices Market in China (2021-2030)
  • Figure 25: Interventional Radiology Devices Market in Japan (2021-2030)
  • Figure 26: Interventional Radiology Devices Market in India (2021-2030)
  • Figure 27: Interventional Radiology Devices Market in Australia (2021-2030)
  • Figure 30: Interventional Radiology Devices Market in South Korea (2021-2030)
  • Figure 31: Interventional Radiology Devices Market in Rest of APAC (2021-2030)
  • Figure 32: Interventional Radiology Devices Market in Rest of World (2021-2030)
  • Figure 33: Interventional Radiology Devices Market in RoW by Region (2021-2030)
  • Figure 34: Interventional Radiology Devices Market in Middle East (2021-2030)
  • Figure 35: Interventional Radiology Devices Market in Africa (2021-2030)
  • Figure 36: Interventional Radiology Devices Market in South America (2021-2030)
  • Figure 37: Market Drivers
  • Figure 38: Market Barriers
  • Figure 39: Marker Opportunities
  • Figure 40: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0561

Interventional Radiology Devices Market By Product Type (MRI Systems, CT Scanners, Ultrasound Imaging Systems, Angiography Systems, Biopsy Devices, And Others), By Application (Cardiology, Oncology, Urology, Gastroenterology, Obstetrics, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing patient pool due to increasing prevalence of chronic disorders & cancer and due to increasing number of geriatric patients globally and the surging awareness and demand of minimally invasive treatment worldwide

Global interventional radiology devices market is expected to grow at a CAGR of 5.23% during the forecast period of 2024-2030. The increase in demand for interventional radiology devices is primarily attributed to the increasing patient pool due to an increasing prevalence of chronic disorders & cancer and due to the increasing number of geriatric patients globally. The interventional radiology devices works on minimally invasive techniques so it involves less severe surgical procedures, thereby leading to less hospitalization period. Thus, the rising demand of the reducing healthcare expenditure across the world is anticipated to bolster the market of the devices. Furthermore, the rising awareness and the demand of minimally invasive techniques and the technological advancements in the devices such as illumination rendering technology, real-time images, and others across the world are anticipated to bolster the market, thereby contributing to the growth of the interventional radiology devices market during the forecast period from 2024-2030.

Interventional Radiology Devices Market Dynamics:

The interventional radiology devices market is witnessing a growth in product demand owing to various reasons.

The increasing patient pool worldwide is increasing the demand of the interventional radiology devices in the market. For instance, the increasing prevalence of cardiovascular disorders such as, heart failure and stroke worldwide due to various factors such as, genetic, age, obesity, and unhealthy lifestyles and increasing number of geriatric patients prone to chronic disorders across the world are anticipated to bolster the market. According to World Health Organization (WHO) 2022, in 2019, cardiovascular diseases (CVDs) was one of the leading cause of death globally. It was estimated that around 17.9 million people died from CVDs in 2019, representing 32% of all the global deaths. It was also estimated that out of 17.9 million deaths, approximately 85% of them were due to heart attack and stroke. Additionally, as per the same source, it was concluded that over three quarters of CVD deaths take place in low- and middle-income countries. WHO concluded that most of the cardiovascular diseases can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol. Additionally, the prevalence of heart failure is also rising. According to Global Health Data Exchange 2019, it was estimated that globally, 64.37 million people were suffering from heart failure. In this case, the increasing prevalence will increase the demand of many interventional radiology devices such as embolization devices, MRI devices for the diagnosis and treatment of the cardiovascular disorders. Thus, the increasing prevalence of chronic disorders globally will increase the patient number, thereby increasing the demand of the interventional radiology devices, therefore anticipated to bolster the overall market growth in the study period of 2022 - 2028.

Moreover, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or more. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion globally. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of person that are aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Thus, the number of geriatric population is increasing which will in turn affect the prevalence of chronic ailments as age is one of the major risk factor for these disorders. The increased prevalence of chronic disorder will ultimately increase the overall patient pool, thereby leading to the increased demand of the interventional radiology devices in the market. Hence, the above factor will bolster the market of interventional radiology devices in the forecast period.

Moreover, majority of the interventional radiology devices are minimally invasive devices as these devices do not provide any major incisions on the body which ultimately reduces the hospitalization stay, thereby resulting in the early recovery of the patient. Therefore, the surging need of the less hospitalization stay and cost will increase the demand of such devices. Therefore, the above factor is anticipated to propel the overall market growth of the interventional radiology devices in the year 2023 - 2028.

Thus, due to the increasing patient number globally, increasing prevalence of chronic disorders and rising need of less hospitalization cost, will pave the way to a rising demand for interventional radiology devices, in turn increasing the interventional radiology devices market growth.

However, higher costs of radiology devices and lack of skilled professionals in remote areas may hinder the overall market growth of the interventional radiology devices.

The ongoing COVID-19 pandemic has slightly impacted the market for interventional radiology devices. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients suffering from cancers and other chronic disorders were not a priority in comparison to the patients that were suffering from coronavirus. The production of certain medical devices was shut down. Furthermore, surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, many surgical centers have postponed and canceled the semi-urgent and elective cases. However, with masses being vaccinated, the interventional radiology devices market has picked momentum.

Interventional Radiology Devices Market Segment Analysis:

Interventional Radiology Devices Market by Product Type (MRI Systems, CT Scanners, Ultrasound Imaging Systems, Angiography Systems, Biopsy Devices, and Others), by Application (Cardiology, Oncology, Urology, Gastroenterology, Obstetrics, and Others), by End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the interventional radiology devices market, the oncology interventional radiology devices are estimated to hold a significant share in the interventional radiology devices market during the forecast period (2024-2030). This can be ascribed to the increasing prevalence of cancer globally and due to wide application circle associated with the segment.

According to the study conducted by the World Health Organization (WHO), it was estimated that cancer is one of the leading cause of the death globally. As per what the WHO had stated, cancer has nearly caused 10 million deaths in the year 2020. The most common cancers are breast, lung, colon and rectum and prostate cancers with breast cancer reported 2.26 million cases globally in the year 2020. Also in the year 2020, globally, there were 2.21 million cases of lung cancer, 1.93 million cases of colon and rectum cancer, and 1.41 million cases of prostate cancer. As per the same source it was estimated that each year, approximately 400,000 children develop cancer. The increasing prevalence of cancers globally will increase the demand of interventional radiology devices used in cancer. Therefore, increasing the overall market growth of the interventional radiology devices in the forecast period.

Moreover, tobacco use, alcohol consumption, unhealthy diet, physical inactivity and air pollution are risk factors for cancer and other non-communicable diseases. The increasing use of tobacco among the people will increase the prevalence of cancer, thereby increasing the demand of the oncology segment in the interventional radiology devices. For instance, according to American Lung Association, State of Tobacco Control 2022, a 2022 study found that menthol cigarettes were responsible for 1.5 million new smokers among African Americans in 2022. The study concluded that from 2019 to 2022, disposable e-cigarette use skyrocketed by more than 23 times among high school e-cigarette users (from 2.4% to 55.8%) and more than 14 times among middle school e-cigarette users (from 3% to 43.8%). Additionally, according to National Youth Tobacco Survey 2020, it was estimated that in 2019-2020 more than 23.6% of high school students in the U.S. use at least one tobacco product, including e-cigarettes. As per the same source, smoking is the number one preventable cause of death in the U.S. killing over 480,000 people per year. The increasing use of tobacco will increase the prevalence of cancer, thereby increasing the demand of oncology segment in the year 2023 - 2028.

Thus, owing to the increasing prevalence of cancer, surging use of tobacco is a risk factor, there will be an increase in the demand for oncology segment in interventional radiology devices, which in turn will drive the interventional radiology devices market growth.

North America is expected to dominate the overall Interventional Radiology Devices Market:

Among all the regions, North America is expected to account for the significant share in the global interventional radiology devices market.

Increasing patient pool in the region and the rising need in the improvement in the quality of the patient care will increase the product demand in the North America. Further, the increasing prevalence of chronic disorders such as diabetes, cardiovascular disorders, hypertension, infections, and many more due to high consumption of processed food & lifestyle changes, and growing incidence of obesity is anticipated to overall propel the market growth of the system in the region. Additionally, increasing number of geriatric population susceptible to chronic medical ailments such as diabetes, neurological disorders, and cardiovascular diseases, and other will increase the demand for interventional radiology devices in North America, leading to a rise in the overall interventional radiology devices market growth.

For instance, as per the data published by the International Diabetes Federation (IDF), Diabetes Atlas Tenth edition 2022, in the year 2023, approximately 51 million adults (20-79 years) were living with diabetes in North America and the total number of people living with diabetes is projected to rise to 7 million by 2030 and 63 million by 2045. As per the same source, it is estimated that almost 1 in 4 (240 million) adults living in North America with diabetes are undiagnosed. Moreover, as per the IDF, Diabetes Atlas Tenth edition 2022, in the year 2023, more than 1.2 million children and adolescents (0-19 years) were living with type 1 diabetes and one in six live births (21 million) were affected by diabetes during pregnancy. As per above statistics, it can be concluded that the prevalence of diabetes mellitus in North America is increasing, this may increase the overall patient number suffering from any disease in the region, ultimately increasing the demand of interventional radiology devices used in the treatment and diagnosis of the chronic disorders. Thus, increasing the overall market growth of interventional radiology devices in the forecast period.

Furthermore, unhealthy life is contributing for an increase in the prevalence of chronic disease like cardiovascular disease and hypertension. Adults who eat a healthy diet live longer, have a lower risk of obesity, heart disease, type 2 diabetes, and certain cancers. Most Americans, however, do not follow a healthy lifestyle. As per the Centers for Disease Control and Prevention (CDC), 2022, fewer than 1 in 10 adults and adolescents eat enough fruits and vegetables, and 9 in 10 Americans aged 20 years or older consume more than the recommended amount of sodium. The unhealthy lifestyle will increase the prevalence of chronic disorders in the forecast period owing to increase the demand of interventional radiology devices in the North America market.

For instance, according to Government of Canada 2022, by the year 2030 seniors are expected to over 9.5 million and make up 23% of Canadians. Moreover, as per the same source, by 2036, the average life expectancy at birth for women will rise to 86.2 years from the current 84.2 and to 82.9 years from the current 80 for men. Geriatric patients are more susceptible to cancer and chronic ailments owing to the increased hospital admissions. This will increase the demand of the interventional radiology devices used in the treatment and diagnosis of chronic disorders in the geriatric patients, thereby leading to the increase demand of the interventional radiology devices in the North America in the forecast period of 2022 - 2028.

Thus, all the above-mentioned factors are anticipated to propel the market for interventional radiology devices in the North America.

Interventional Radiology Devices Market Key Players:

Some of the key market players operating in the Interventional Radiology Devices market include General Electric, Koninklijke Philips N.V., Carestream Health, ESAOTE SPA, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Samsung Medison Co., Ltd., Medtronic Plc, Agfa-Gevaert Group, Teleflex Incorporated, Cook, Analogic Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Trivitron Healthcare, Stryker Corporation, Olympus Corporation, Toshiba Medical Systems, among others.

Recent Developmental Activities in the Interventional Radiology Devices Market:

In May 2022, XACT Robotics, developer of the world's first and only comprehensive robotic system for interventional radiology, announced that the XACT ACE Robotic System received US Food and Drug Administration (FDA) clearance for a modification to its cleared XACT ACE Robotic System designed to support robotic insertion and steering of ablation probes during ablation clinical procedures.

In March 2022, Guerbet, a global leader in medical imaging, announced the launch of microcatheters and a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions.

In April 2022, Siemens Healthineers AG, a leading medical technology, announced that it has successfully completed the acquisition of Varian Medical Systems, Inc., an American radiation oncology treatments and software maker. The combined company is creating a unique, highly integrated portfolio of imaging, laboratory diagnostics, artificial intelligence and treatment for the global to fight against cancer.

In December 2020, Samsung Electronics Co. Ltd, a global leading medical device company, announced the launch of their premium diagnostic imaging solutions in ultrasound, digital radiography, and mobile computed tomography at the Radiological Society of North America (RSNA) 2020. This strategic initiative assisted the company in expanding their product portfolio in interventional radiology industry.

Key Takeaways from the Interventional Radiology Devices Market Report Study

  • Market size analysis for current interventional radiology devices market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the interventional radiology devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global interventional radiology devices market.
  • Various opportunities available for the other competitor in the interventional radiology devices market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current interventional radiology devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for interventional radiology devices market growth in the coming future?

Target Audience who can be benefited from this Interventional Radiology Devices Market Report Study

  • Interventional radiology devices products providers
  • Research organizations and consulting companies
  • Interventional radiology devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in interventional radiology devices
  • Various End-users who want to know more about the interventional radiology devices market and latest technological developments in the interventional radiology devices market.

Frequently Asked Questions for Interventional Radiology Devices Market:

1. What are interventional radiology devices?

An Interventional Radiology (IR) Device, refers to a range of medical devices and techniques which rely on the use radiological image guidance such as X-ray fluoroscopy, ultrasound, computed tomography [CT] or magnetic resonance imaging [MRI], and others to precisely target therapy. Most IR treatments are minimally invasive alternatives to open and laparoscopic surgery.

2. What is the market for global interventional radiology devices?

Global interventional radiology devices market is expected to grow at a CAGR of 5.23% during the forecast period of 2024-2030.

3. What are the drivers for the global interventional radiology devices market?

The interventional radiology devices market is witnessing a positive market growth owing to the increasing patient pool due to the increasing prevalence of chronic disorders & cancer and due to increasing number of geriatric patients globally. Additionally, the rising demand for reducing healthcare expenditure due to lesser hospital stay with the use of interventional radiology devices will propel the overall market growth of the device in the upcoming years. Furthermore, the surging awareness and demand of minimally invasive treatment and the technological advancements in the devices such as illumination rendering technology, real-time images, and others across the world are anticipated to bolster the market.

4. Who are the key players operating in the global interventional radiology devices market?

Some of the key market players operating in the interventional radiology devices market include General Electric, Koninklijke Philips N.V., Carestream Health, ESAOTE SPA, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Samsung Medison Co., Ltd., Medtronic Plc, Agfa-Gevaert Group, Teleflex Incorporated, Cook, Analogic Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Trivitron Healthcare, Stryker Corporation, Olympus Corporation, Toshiba Medical Systems, and others.

5. Which region has the highest share in Interventional Radiology Devices market?

North America is expected to hold the highest share in the revenue in the interventional radiology devices market during the forecast period. Increasing patient pool due to increasing prevalence of chronic disorders & cancer and due to increasing number of geriatric patients globally and increasing demand and awareness of the minimally invasive techniques will propel the interventional radiology devices in the North America, leading to a rise in the overall interventional radiology devices market growth in this region.

Table of Contents

1.Interventional Radiology Devices Market Report Introduction

2.Interventional Radiology Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Interventional Radiology Devices Market Key Factors Analysis

  • 4.1. Interventional Radiology Devices Market Drivers
    • 4.1.1. Increasing patient pool due to increasing prevalence of chronic disorders & cancer and due to increasing number of geriatric patients globally
    • 4.1.2. Rising demand for reducing healthcare expenditure due to lesser hospital stay
    • 4.1.3. Surging awareness and demand of minimally invasive treatment
    • 4.1.4. Technological advancements in the devices such as illumination rendering technology, real-time images, and others
  • 4.2. Interventional Radiology Devices Market Restraints and Challenges
    • 4.2.1. Higher costs of radiology devices
    • 4.2.2. Lack of skilled professionals in remote areas
  • 4.3. Interventional Radiology Devices Market Opportunities
    • 4.3.1. Increasing demand of the systems with the advanced algorithms, artificial intelligence, and others

5. Interventional Radiology Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Interventional Radiology Devices Market

7. Interventional Radiology Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. MRI Systems
    • 7.1.2. CT Scanners
    • 7.1.3. Ultrasound Imaging Systems
    • 7.1.4. Angiography Systems
    • 7.1.5. Biopsy devices
    • 7.1.6. Others
  • 7.2. By Application
    • 7.2.1. Cardiology
    • 7.2.2. Oncology
    • 7.2.3. Urology
    • 7.2.4. Gastroenterology
    • 7.2.5. Obstetrics
    • 7.2.6. Others
  • 7.3. By End-user
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States
      • 7.4.1.2. Canada
      • 7.4.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. France
      • 7.4.2.2. Germany
      • 7.4.2.3. United Kingdom
      • 7.4.2.4. Italy
      • 7.4.2.5. Spain
      • 7.4.2.6. Russia
      • 7.4.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China
      • 7.4.3.2. Japan
      • 7.4.3.3. India
      • 7.4.3.4. Australia
      • 7.4.3.5. South Korea
      • 7.4.3.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East
      • 7.4.4.2. Africa
      • 7.4.4.3. South America

8. Interventional Radiology Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Interventional Radiology Devices Market Company and Product Profiles

  • 9.1. General Electric
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Koninklijke Philips N.V.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Carestream Health
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. ESAOTE SPA
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Hitachi, Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Hologic, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Shimadzu Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Siemens Healthcare GmbH
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. CANON MEDICAL SYSTEMS CORPORATION
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Samsung Medison Co., Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Medtronic
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Agfa-Gevaert Group
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Teleflex Incorporated
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Cook
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Analogic Corporation
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Trivitron Healthcare
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Stryker Corporation
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Olympus Corporation
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Toshiba Medical Systems
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us